Skip to main content

Methylphenidate Transdermal System Shortage

Last Updated: April 1, 2025
Status: Current

Products Affected - Description
    • Daytrana transdermal system, Noven, 10 mg/9 hours (1.1 mg/hr), patch, 30 count, NDC 68968-5552-03
    • Daytrana transdermal system, Noven, 15 mg/9 hours (1.6 mg/hr), patch, 30 count, NDC 68968-5553-03
    • Daytrana transdermal system, Noven, 20 mg/9 hours (2.2 mg/hr), patch, 30 count, NDC 68968-5554-03
    • Daytrana transdermal system, Noven, 30 mg/9 hours (3.3 mg/hr), patch, 30 count, NDC 68968-5555-03
    • Methylphenidate transdermal system, Mylan (Viatris), 10 mg/9 hours (1.1 mg/hr), patch, 30 count, NDC 00378-8260-93
    • Methylphenidate transdermal system, Mylan (Viatris), 15 mg/9 hours (1.6 mg/hr), patch, 30 count, NDC 00378-8261-93
    • Methylphenidate transdermal system, Mylan (Viatris), 20 mg/9 hours (2.2 mg/hr), patch, 30 count, NDC 00378-8262-93
    • Methylphenidate transdermal system, Mylan (Viatris), 30 mg/9 hours (3.3 mg/hr), patch, 30 count, NDC 00378-8263-93
    • Methylphenidate transdermal system, Padagis, 10 mg/9 hours (1.1 mg/hr), patch, 30 count, NDC 00574-2410-65
    • Methylphenidate transdermal system, Padagis, 15 mg/9 hours (1.6 mg/hr), patch, 30 count, NDC 00574-2415-65
    • Methylphenidate transdermal system, Padagis, 20 mg/9 hours (2.2 mg/hr), patch, 30 count, NDC 00574-2420-65
    • Methylphenidate transdermal system, Padagis, 30 mg/9 hours (3.3 mg/hr), patch, 30 count, NDC 00574-2430-65
Reason for the Shortage
    • Noven has Daytrana patches on back order due to a shortage of an active ingredient.
    • Mylan (Viatris) has methylphenidate patches on back order due to a shortage of an active ingredient.
    • Padagis has methylphenidate patches on back order due to a shortage of an active ingredient. Padagis is the distributor of the authorized generic.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Mylan (Viatris) has all methylphenidate transdermal patches on back order and the company estimates a release date in late-May 2025.
    • Noven has all Daytrana transdermal patches on back order and the company estimates a release date in the second half of 2025.
    • Padagis has methylphenidate transdermal patches on back order and the company estimates a release date in late-August 2025.

Updated

Updated April 1, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created February 28, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer